LCZ696, an Angiotensin Receptor-Neprilysin Inhibitor, Attenuates Vascular Inflammation and Atherosclerosis in Apolipoprotein E-deficient Mice
The Journal of Medical Investigation · 2026 · 73 (1.2) · 116-120
DOI: 10.2152/jmi.73.116 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift The Journal of Medical Investigation, 2026. Verfasst von Juri Maeda und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan. Hauptthemen laut MEDLINE: Angiotensin Receptor Antagonists, Atherosclerosis, Vasculitis. Die Arbeit nennt 27 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiovascular Medicine, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan.
- Department of Cardiovascular Medicine, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.
Zitieren
APA
Maeda, J., Hara, T., Bavuu, O., Fukuda, D., & Sata, M. (2026). LCZ696, an Angiotensin Receptor-Neprilysin Inhibitor, Attenuates Vascular Inflammation and Atherosclerosis in Apolipoprotein E-deficient Mice. The Journal of Medical Investigation, 73(1.2), 116-120. https://doi.org/10.2152/jmi.73.116
Vancouver
Maeda J, Hara T, Bavuu O, Fukuda D, Sata M. LCZ696, an Angiotensin Receptor-Neprilysin Inhibitor, Attenuates Vascular Inflammation and Atherosclerosis in Apolipoprotein E-deficient Mice. The Journal of Medical Investigation. 2026;73(1.2):116-120. doi:10.2152/jmi.73.116
BibTeX
@article{Maeda2026,
author = {Maeda, Juri and Hara, Tomoya and Bavuu, Oyunbileg and Fukuda, Daiju and Sata, Masataka},
title = {LCZ696, an Angiotensin Receptor-Neprilysin Inhibitor, Attenuates Vascular Inflammation and Atherosclerosis in Apolipoprotein E-deficient Mice},
journal = {The Journal of Medical Investigation},
year = {2026},
volume = {73},
number = {1.2},
pages = {116--120},
doi = {10.2152/jmi.73.116}
}
EUVIMED